Collectively, the data suggest the involvement of CD8+ T cells recognizing antigens expressed by autoBLCL, and potentially the same TCC, in the inflammatory process in two distinct mAIL of the same MS patient. This evidence concerns the gene CD8A and myeloid sarcoma.